Breakdown | ||||
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
20.43T | 16.91T | 14.55T | 13.17T | 14.93T | Gross Profit |
4.26T | 3.33T | 2.98T | 2.73T | 3.08T | EBIT |
1.38T | 839.40B | 871.23B | 660.21B | 633.64B | EBITDA |
3.17T | 2.40T | 2.36T | 2.08T | 2.28T | Net Income Common Stockholders |
1.11T | 651.42B | 707.07B | 657.42B | 455.75B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
5.18T | 4.07T | 3.89T | 3.05T | 2.86T | Total Assets |
29.77T | 24.67T | 23.97T | 21.92T | 20.46T | Total Debt |
10.08T | 7.67T | 8.10T | 7.72T | 7.47T | Net Debt |
5.13T | 3.86T | 4.43T | 4.96T | 4.80T | Total Liabilities |
16.77T | 13.12T | 13.20T | 12.55T | 12.18T | Stockholders Equity |
12.70T | 11.23T | 10.47T | 9.08T | 8.01T |
Cash Flow | Free Cash Flow | |||
138.61B | 1.50T | 1.23T | 521.24B | 378.16B | Operating Cash Flow |
747.28B | 2.13T | 1.68T | 1.07T | 979.41B | Investing Cash Flow |
-867.27B | -678.06B | -376.06B | -796.88B | -619.48B | Financing Cash Flow |
918.65B | -1.47T | -615.72B | -283.98B | -87.41B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
76 Outperform | $25.52B | 23.86 | 12.29% | ― | 15.50% | -32.48% | |
75 Outperform | $219.94B | 6.82 | 14.59% | 2.53% | -0.59% | 7.56% | |
74 Outperform | $49.36B | 7.13 | 8.11% | 3.94% | 4.37% | 6.93% | |
73 Outperform | $37.10B | 6.38 | 13.42% | 7.29% | 5.00% | 35.92% | |
70 Outperform | $43.41B | 6.85 | 8.88% | 1.06% | 7.76% | -14.17% | |
61 Neutral | $6.65B | 11.71 | 3.09% | 3.98% | 2.65% | -20.82% | |
53 Neutral | $19.06B | ― | -17.11% | ― | 32.32% | 49.34% |